Hi North - You are the reason I found out about this stock (suspect it was a misdirected message I received from you, but I looked into it anyway). Agree that this is solid science - I do NIH funded research and know that the types of grants they are getting only go to very competent and well regarded researchers with solid ideas. Really like that the company is mostly NIH-funded. While nothing is guaranteed, I am fairly confident that one of their lines of vaccine development will be intriguing enough to prompt a buyout from BP. Suspect it is at least a year away though (after phase I booster results are released next fall as the follow-up to the phase 2 HIV vaccine study that was successful).
News 
Market Data 
Discover 
